Global Therapeutic Nuclear Medicines Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Therapeutic Nuclear Medicines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Radium-223
  • 1.2.3 Lutetium-177
  • 1.2.4 Iodine-131
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Thyroid
  • 1.3.3 Bone Metastasis
  • 1.3.4 Lymphoma
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2017-2028
• 2.2 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Therapeutic Nuclear Medicines Sales by Region
  • 2.4.1 Global Therapeutic Nuclear Medicines Sales by Region (2017-2022)
  • 2.4.2 Global Sales Therapeutic Nuclear Medicines by Region (2023-2028)
• 2.5 Global Therapeutic Nuclear Medicines Revenue by Region
  • 2.5.1 Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022)
  • 2.5.2 Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers
  • 3.1.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Nuclear Medicines in 2021
• 3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturers
  • 3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2021
• 3.3 Global Therapeutic Nuclear Medicines Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Therapeutic Nuclear Medicines Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Therapeutic Nuclear Medicines Sales by Type
  • 4.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Type (2017-2022)
  • 4.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• 4.2 Global Therapeutic Nuclear Medicines Revenue by Type
  • 4.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• 4.3 Global Therapeutic Nuclear Medicines Price by Type
  • 4.3.1 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
  • 4.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Therapeutic Nuclear Medicines Sales by Application
  • 5.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Application (2017-2022)
  • 5.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• 5.2 Global Therapeutic Nuclear Medicines Revenue by Application
  • 5.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• 5.3 Global Therapeutic Nuclear Medicines Price by Application
  • 5.3.1 Global Therapeutic Nuclear Medicines Price by Application (2017-2022)
  • 5.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Therapeutic Nuclear Medicines Market Size by Type
  • 6.1.1 North America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
  • 6.1.2 North America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
• 6.2 North America Therapeutic Nuclear Medicines Market Size by Application
  • 6.2.1 North America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
  • 6.2.2 North America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
• 6.3 North America Therapeutic Nuclear Medicines Market Size by Country
  • 6.3.1 North America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
  • 6.3.2 North America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Therapeutic Nuclear Medicines Market Size by Type
  • 7.1.1 Europe Therapeutic Nuclear Medicines Sales by Type (2017-2028)
  • 7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
• 7.2 Europe Therapeutic Nuclear Medicines Market Size by Application
  • 7.2.1 Europe Therapeutic Nuclear Medicines Sales by Application (2017-2028)
  • 7.2.2 Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
• 7.3 Europe Therapeutic Nuclear Medicines Market Size by Country
  • 7.3.1 Europe Therapeutic Nuclear Medicines Sales by Country (2017-2028)
  • 7.3.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Type
  • 8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
• 8.2 Asia Pacific Therapeutic Nuclear Medicines Market Size by Application
  • 8.2.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
• 8.3 Asia Pacific Therapeutic Nuclear Medicines Market Size by Region
  • 8.3.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Therapeutic Nuclear Medicines Market Size by Type
  • 9.1.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
  • 9.1.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
• 9.2 Latin America Therapeutic Nuclear Medicines Market Size by Application
  • 9.2.1 Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
  • 9.2.2 Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
• 9.3 Latin America Therapeutic Nuclear Medicines Market Size by Country
  • 9.3.1 Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
  • 9.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Type
  • 10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Application
  • 10.2.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country
  • 10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Novartis AG
  • 11.1.1 Novartis AG Corporation Information
  • 11.1.2 Novartis AG Overview
  • 11.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Novartis AG Recent Developments
• 11.2 Bayer
  • 11.2.1 Bayer Corporation Information
  • 11.2.2 Bayer Overview
  • 11.2.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Bayer Recent Developments
• 11.3 China Isotope & Radiation
  • 11.3.1 China Isotope & Radiation Corporation Information
  • 11.3.2 China Isotope & Radiation Overview
  • 11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 China Isotope & Radiation Recent Developments
• 11.4 Q BioMed
  • 11.4.1 Q BioMed Corporation Information
  • 11.4.2 Q BioMed Overview
  • 11.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Q BioMed Recent Developments
• 11.5 Curium Pharmaceuticals
  • 11.5.1 Curium Pharmaceuticals Corporation Information
  • 11.5.2 Curium Pharmaceuticals Overview
  • 11.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Curium Pharmaceuticals Recent Developments
• 11.6 Jubilant DraxImage
  • 11.6.1 Jubilant DraxImage Corporation Information
  • 11.6.2 Jubilant DraxImage Overview
  • 11.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Jubilant DraxImage Recent Developments
• 11.7 Dongcheng
  • 11.7.1 Dongcheng Corporation Information
  • 11.7.2 Dongcheng Overview
  • 11.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Dongcheng Recent Developments
• 11.8 Lantheus
  • 11.8.1 Lantheus Corporation Information
  • 11.8.2 Lantheus Overview
  • 11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Lantheus Recent Developments
• 11.9 Acrotech Biopharma.
  • 11.9.1 Acrotech Biopharma. Corporation Information
  • 11.9.2 Acrotech Biopharma. Overview
  • 11.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Acrotech Biopharma. Recent Developments
• 11.10 Progenics Pharmaceuticals
  • 11.10.1 Progenics Pharmaceuticals Corporation Information
  • 11.10.2 Progenics Pharmaceuticals Overview
  • 11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Progenics Pharmaceuticals Recent Developments
• 11.11 International Isotopes
  • 11.11.1 International Isotopes Corporation Information
  • 11.11.2 International Isotopes Overview
  • 11.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 International Isotopes Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Therapeutic Nuclear Medicines Industry Chain Analysis
• 12.2 Therapeutic Nuclear Medicines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Therapeutic Nuclear Medicines Production Mode & Process
• 12.4 Therapeutic Nuclear Medicines Sales and Marketing
  • 12.4.1 Therapeutic Nuclear Medicines Sales Channels
  • 12.4.2 Therapeutic Nuclear Medicines Distributors
• 12.5 Therapeutic Nuclear Medicines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Therapeutic Nuclear Medicines Industry Trends
• 13.2 Therapeutic Nuclear Medicines Market Drivers
• 13.3 Therapeutic Nuclear Medicines Market Challenges
• 13.4 Therapeutic Nuclear Medicines Market Restraints

14 Key Findings in The Global Therapeutic Nuclear Medicines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Radium-223
• Table 3. Major Manufacturers of Lutetium-177
• Table 4. Major Manufacturers of Iodine-131
• Table 5. Major Manufacturers of Other
• Table 6. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 8. Global Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
• Table 9. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)
• Table 10. Global Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
• Table 11. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2023-2028)
• Table 12. Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
• Table 13. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2017-2022)
• Table 14. Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
• Table 15. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2023-2028)
• Table 16. Global Therapeutic Nuclear Medicines Sales by Manufacturers (2017-2022) & (K Units)
• Table 17. Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2017-2022)
• Table 18. Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 19. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2017-2022)
• Table 20. Therapeutic Nuclear Medicines Price by Manufacturers (2017-2022) &(USD/Unit)
• Table 21. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 22. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2021)
• Table 23. Therapeutic Nuclear Medicines Manufacturing Base Distribution and Headquarters
• Table 24. Manufacturers Therapeutic Nuclear Medicines Product Offered
• Table 25. Date of Manufacturers Enter into Therapeutic Nuclear Medicines Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
• Table 28. Global Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
• Table 29. Global Therapeutic Nuclear Medicines Sales Share by Type (2017-2022)
• Table 30. Global Therapeutic Nuclear Medicines Sales Share by Type (2023-2028)
• Table 31. Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
• Table 32. Global Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
• Table 33. Global Therapeutic Nuclear Medicines Revenue Share by Type (2017-2022)
• Table 34. Global Therapeutic Nuclear Medicines Revenue Share by Type (2023-2028)
• Table 35. Therapeutic Nuclear Medicines Price by Type (2017-2022) & (USD/Unit)
• Table 36. Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028) & (USD/Unit)
• Table 37. Global Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
• Table 38. Global Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
• Table 39. Global Therapeutic Nuclear Medicines Sales Share by Application (2017-2022)
• Table 40. Global Therapeutic Nuclear Medicines Sales Share by Application (2023-2028)
• Table 41. Global Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
• Table 42. Global Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
• Table 43. Global Therapeutic Nuclear Medicines Revenue Share by Application (2017-2022)
• Table 44. Global Therapeutic Nuclear Medicines Revenue Share by Application (2023-2028)
• Table 45. Therapeutic Nuclear Medicines Price by Application (2017-2022) & (USD/Unit)
• Table 46. Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028) & (USD/Unit)
• Table 47. North America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
• Table 48. North America Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
• Table 49. North America Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
• Table 50. North America Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
• Table 51. North America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
• Table 52. North America Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
• Table 53. North America Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
• Table 54. North America Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
• Table 55. North America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
• Table 56. North America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
• Table 57. North America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
• Table 58. North America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
• Table 59. Europe Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
• Table 60. Europe Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
• Table 61. Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
• Table 62. Europe Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
• Table 63. Europe Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
• Table 64. Europe Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
• Table 65. Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
• Table 66. Europe Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
• Table 67. Europe Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
• Table 68. Europe Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
• Table 69. Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
• Table 70. Europe Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
• Table 71. Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
• Table 72. Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
• Table 73. Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
• Table 74. Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
• Table 75. Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
• Table 76. Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
• Table 77. Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
• Table 78. Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
• Table 79. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2022) & (K Units)
• Table 80. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2023-2028) & (K Units)
• Table 81. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2022) & (US$ Million)
• Table 82. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2023-2028) & (US$ Million)
• Table 83. Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
• Table 84. Latin America Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
• Table 85. Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
• Table 86. Latin America Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
• Table 87. Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
• Table 88. Latin America Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
• Table 89. Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
• Table 90. Latin America Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
• Table 91. Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
• Table 92. Latin America Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
• Table 93. Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
• Table 94. Latin America Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
• Table 95. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2022) & (K Units)
• Table 96. Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2023-2028) & (K Units)
• Table 97. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2022) & (US$ Million)
• Table 98. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2023-2028) & (US$ Million)
• Table 99. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2022) & (K Units)
• Table 100. Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2023-2028) & (K Units)
• Table 101. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2022) & (US$ Million)
• Table 102. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2023-2028) & (US$ Million)
• Table 103. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2022) & (K Units)
• Table 104. Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2023-2028) & (K Units)
• Table 105. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2022) & (US$ Million)
• Table 106. Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2023-2028) & (US$ Million)
• Table 107. Novartis AG Corporation Information
• Table 108. Novartis AG Description and Major Businesses
• Table 109. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 110. Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 111. Novartis AG Recent Developments
• Table 112. Bayer Corporation Information
• Table 113. Bayer Description and Major Businesses
• Table 114. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 115. Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Bayer Recent Developments
• Table 117. China Isotope & Radiation Corporation Information
• Table 118. China Isotope & Radiation Description and Major Businesses
• Table 119. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 120. China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. China Isotope & Radiation Recent Developments
• Table 122. Q BioMed Corporation Information
• Table 123. Q BioMed Description and Major Businesses
• Table 124. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 125. Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Q BioMed Recent Developments
• Table 127. Curium Pharmaceuticals Corporation Information
• Table 128. Curium Pharmaceuticals Description and Major Businesses
• Table 129. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 130. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. Curium Pharmaceuticals Recent Developments
• Table 132. Jubilant DraxImage Corporation Information
• Table 133. Jubilant DraxImage Description and Major Businesses
• Table 134. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 135. Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Jubilant DraxImage Recent Developments
• Table 137. Dongcheng Corporation Information
• Table 138. Dongcheng Description and Major Businesses
• Table 139. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 140. Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Dongcheng Recent Developments
• Table 142. Lantheus Corporation Information
• Table 143. Lantheus Description and Major Businesses
• Table 144. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 145. Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Lantheus Recent Developments
• Table 147. Acrotech Biopharma. Corporation Information
• Table 148. Acrotech Biopharma. Description and Major Businesses
• Table 149. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 150. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. Acrotech Biopharma. Recent Developments
• Table 152. Progenics Pharmaceuticals Corporation Information
• Table 153. Progenics Pharmaceuticals Description and Major Businesses
• Table 154. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 155. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Progenics Pharmaceuticals Recent Developments
• Table 157. International Isotopes Corporation Information
• Table 158. International Isotopes Description and Major Businesses
• Table 159. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 160. International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. International Isotopes Recent Developments
• Table 162. Key Raw Materials Lists
• Table 163. Raw Materials Key Suppliers Lists
• Table 164. Therapeutic Nuclear Medicines Distributors List
• Table 165. Therapeutic Nuclear Medicines Customers List
• Table 166. Therapeutic Nuclear Medicines Market Trends
• Table 167. Therapeutic Nuclear Medicines Market Drivers
• Table 168. Therapeutic Nuclear Medicines Market Challenges
• Table 169. Therapeutic Nuclear Medicines Market Restraints
• Table 170. Research Programs/Design for This Report
• Table 171. Key Data Information from Secondary Sources
• Table 172. Key Data Information from Primary Sources

List of Figures

• Figure 1. Therapeutic Nuclear Medicines Product Picture
• Figure 3. Global Therapeutic Nuclear Medicines Market Share by Type in 2021 & 2028
• Figure 3. Radium-223 Product Picture
• Figure 4. Lutetium-177 Product Picture
• Figure 5. Iodine-131 Product Picture
• Figure 6. Other Product Picture
• Figure 7. Global Therapeutic Nuclear Medicines Market Share by Application in 2021 & 2028
• Figure 8. Thyroid
• Figure 9. Bone Metastasis
• Figure 10. Lymphoma
• Figure 11. Other
• Figure 12. Therapeutic Nuclear Medicines Report Years Considered
• Figure 13. Global Therapeutic Nuclear Medicines Sales 2017-2028 (K Units)
• Figure 14. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 15. Global Therapeutic Nuclear Medicines Revenue 2017-2028 (US$ Million)
• Figure 16. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 17. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2017-2022)
• Figure 18. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2023-2028)
• Figure 19. North America Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
• Figure 20. North America Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
• Figure 21. Europe Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
• Figure 22. Europe Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Asia-Pacific Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
• Figure 24. Asia-Pacific Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. Latin America Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
• Figure 26. Latin America Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
• Figure 27. Middle East & Africa Therapeutic Nuclear Medicines Sales YoY (2017-2028) & (K Units)
• Figure 28. Middle East & Africa Therapeutic Nuclear Medicines Revenue YoY (2017-2028) & (US$ Million)
• Figure 29. The Therapeutic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 30. The Top 5 and 10 Largest Manufacturers of Therapeutic Nuclear Medicines in the World: Market Share by Therapeutic Nuclear Medicines Revenue in 2021
• Figure 31. Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 32. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• Figure 33. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• Figure 34. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• Figure 35. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• Figure 36. North America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• Figure 37. North America Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• Figure 38. North America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• Figure 39. North America Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• Figure 40. North America Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
• Figure 41. North America Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
• Figure 42. U.S. Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 43. Canada Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 44. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• Figure 45. Europe Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• Figure 46. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• Figure 47. Europe Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• Figure 48. Europe Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
• Figure 49. Europe Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
• Figure 50. Germany Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 51. France Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 52. U.K. Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 53. Italy Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 54. Russia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 55. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• Figure 56. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• Figure 57. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• Figure 58. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• Figure 59. Asia Pacific Therapeutic Nuclear Medicines Sales Share by Region (2017-2028)
• Figure 60. Asia Pacific Therapeutic Nuclear Medicines Revenue Share by Region (2017-2028)
• Figure 61. China Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 62. Japan Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 63. South Korea Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 64. India Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 65. Australia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 66. Taiwan Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 67. Indonesia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 68. Thailand Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 69. Malaysia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 70. Philippines Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 71. Latin America Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• Figure 72. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• Figure 73. Latin America Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• Figure 74. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• Figure 75. Latin America Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
• Figure 76. Latin America Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
• Figure 77. Mexico Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 78. Brazil Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 79. Argentina Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 80. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
• Figure 81. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
• Figure 82. Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
• Figure 83. Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
• Figure 84. Middle East and Africa Therapeutic Nuclear Medicines Sales Share by Country (2017-2028)
• Figure 85. Middle East and Africa Therapeutic Nuclear Medicines Revenue Share by Country (2017-2028)
• Figure 86. Turkey Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 87. Saudi Arabia Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 88. UAE Therapeutic Nuclear Medicines Revenue (2017-2028) & (US$ Million)
• Figure 89. Therapeutic Nuclear Medicines Value Chain
• Figure 90. Therapeutic Nuclear Medicines Production Process
• Figure 91. Channels of Distribution
• Figure 92. Distributors Profiles
• Figure 93. Bottom-up and Top-down Approaches for This Report
• Figure 94. Data Triangulation
• Figure 95. Key Executives Interviewed